Beckman Coulter to Buy Remainder of NexGen | GenomeWeb
NEW YORK (GenomeWeb News) – Beckman Coulter said yesterday it has agreed to buy the remaining 80.1 percent of NexGen Diagnostics, a spin-out of Lumigen, which it bought in late 2006 for $185 million. 
NexGen owns intellectual property that Beckman Coulter hopes to use for immunoassay and nucleic acid-based diagnostic testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.